Compass Therapeutics (CMPX) Return on Assets (ROA)

Price: $1.46
Market Cap: $201.89M
Avg Volume: 2.08M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.187
52W Range: $0.765-4.08
Website: Compass Therapeutics

Compass Therapeutics Return on Assets (ROA) Summary

Compass Therapeutics's ROA indicates the return generated on the company's assets:

  • Annual: -27.09%
  • Quarterly: -7.03%
  • TTM: -32.02%

What is Return on Assets (ROA)?

Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.

Related Metrics

Other important metrics to assess Compass Therapeutics's profitability include:

  • ROE (Return on Equity) - measures the return generated on shareholders' equity:
    • Annual: -28.61%
    • Quarterly: -7.57%
    • TTM: -32.37%
  • ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
    • Annual: -33.51%
    • Quarterly: -8.42%
    • TTM: -40.00%
  • Return on Tangible Assets - measures the return generated on the company's tangible assets:
    • Annual: -27.09%
    • Quarterly: -7.03%
    • TTM: -32.02%
  • Profit Margin - shows the percentage of revenue that has turned into profit:
    • Annual: 0.00%
    • Quarterly: 0.00%
    • TTM: -1292.88%

These metrics provide insights into Compass Therapeutics's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROA

-27.09%

Quarterly ROA

-7.03%

TTM ROA

-32.02%

Compass Therapeutics Historical ROA
45.69%45.69%-7.66%-7.66%-61.01%-61.01%-114.36%-114.36%ROAJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Historical ROE
89.17%89.17%34.83%34.83%-19.51%-19.51%-73.85%-73.85%ROEJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Historical ROIC
39.29%39.29%-17.35%-17.35%-73.99%-73.99%-130.63%-130.63%ROICJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Historical Profit Margin
200.00%200.00%160.00%160.00%120.00%120.00%80.00%80.00%40.00%40.00%0.00%0.00%Profit MarginJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Historical Return on Tangible Assets
45.69%45.69%-7.66%-7.66%-61.01%-61.01%-114.36%-114.36%Return on Tangible AssetsJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024

Compass Therapeutics Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2023.

Year ROA ROE ROIC Profit Margin Return on Tangible Assets
2023 -27.09% -28.61% -33.51% 0.00% -27.09%
2022 -18.43% -20.26% -21.17% 0.00% -18.43%
2021 -53.69% -58.93% -57.07% 0.00% -53.69%
2020 -56.83% -73.85% -56.50% 0.00% -56.83%
2020 -114.36% 29.29% -130.63% 0.00% -114.36%
2019 -59.24% 45.16% -64.19% 0.00% -59.24%

Related Metrics

Explore detailed financial metrics and analysis for CMPX.